Penciclovir Sodium is a pharmaceutical active ingredient belonging to the antiviral class of synthetic acyclic guanine nucleoside analogues. It is the sodium salt form of penciclovir and is used in pharmaceutical development for antiviral applications, particularly those associated with herpesvirus infections. Penciclovir Sodium API is characterized by CAS No. 97845-62-0, molecular formula C10H14N5NaO3, and molecular weight 275.24 g/mol.
Penciclovir Sodium works through a targeted antiviral mechanism involving inhibition of viral DNA replication. After entering virus-infected cells, the penciclovir moiety undergoes phosphorylation to form its active triphosphate metabolite. This active metabolite inhibits viral DNA polymerase and interferes with the synthesis and replication of viral DNA. The mechanism provides selective activity against susceptible herpesviruses.
As a pharmaceutical API, Penciclovir Sodium requires appropriate control of identity, assay, related substances, residual solvents, water content, elemental impurities, and other applicable quality attributes. Validated analytical methods such as HPLC, UPLC, mass spectrometry, and other complementary techniques can be used for characterization and quality control.
Penciclovir Sodium is primarily relevant to the development and manufacture of antiviral pharmaceutical products. Its pharmacological activity makes it particularly important in formulations designed to address infections caused by susceptible herpes simplex viruses.
The API can be used in:
Penciclovir is converted inside infected cells into phosphorylated metabolites. Viral thymidine kinase plays an important role in the initial phosphorylation step, followed by cellular kinases that produce the active triphosphate metabolite.
Penciclovir triphosphate acts on viral DNA polymerase, reducing the ability of the virus to efficiently synthesize viral DNA. This disruption of viral DNA replication contributes to the antiviral effect.
The intracellular activation of penciclovir is an important feature of its pharmacological activity and contributes to its selectivity toward infected cells.
Penciclovir Sodium is chemically different from the parent penciclovir free form because the sodium salt contains sodium as part of its chemical composition. Therefore, API documentation should clearly identify the material as Penciclovir Sodium rather than using the molecular weight or formula of penciclovir alone.
The sodium salt has a molecular weight of 275.24 g/mol and molecular formula C10H14N5NaO3. Its CAS number is 97845-62-0.
Maintaining the correct salt form is particularly important for pharmaceutical specifications, analytical standards, regulatory documentation, formulation calculations, and batch records.
Consistent quality is essential when Penciclovir Sodium is used as a pharmaceutical active ingredient. A comprehensive quality-control program should verify the chemical identity and purity of the API while monitoring potentially relevant process-related and degradation impurities.
Typical quality-control activities may include:
The numerical acceptance limits for assay, impurities, water, and other quality attributes should be taken from the applicable validated API specification rather than applying generic values.
HPLC and UPLC methods can provide quantitative assessment of Penciclovir Sodium and its related substances. Chromatographic methods can also be developed as stability-indicating procedures to monitor degradation during storage.
Mass spectrometry can provide additional confirmation of molecular identity and molecular mass. Other spectroscopic techniques may be used as complementary identification tools.
Water content should be determined using a validated analytical method when it is a defined critical quality attribute. Residual solvents should be evaluated according to the manufacturing process and applicable pharmaceutical requirements.
Elemental impurities should likewise be controlled using a scientifically justified risk assessment and appropriate validated analytical procedures.
Manufacturing of Penciclovir Sodium involves controlled chemical synthesis followed by purification and conversion to the desired sodium-salt form. The manufacturing process should be designed to consistently achieve the required chemical purity and physical characteristics.
Important process stages can include:
Process controls help minimize residual solvents, organic impurities, degradation products, and other unwanted substances.
Penciclovir Sodium remains relevant to pharmaceutical research because of the established antiviral mechanism of the penciclovir active moiety. Its use as a defined sodium-salt API makes accurate characterization particularly important during formulation development and analytical testing.
Pharmaceutical development teams may evaluate the API's physicochemical properties, stability, compatibility with excipients, dissolution behavior, and impurity profile before selecting appropriate formulation and manufacturing processes.
For topical antiviral products, formulation scientists may also investigate factors such as API concentration, vehicle compatibility, physical stability, skin-delivery characteristics, and product performance.
Penciclovir Sodium API should be stored and handled according to its validated stability data and applicable product specification. Proper container closure and environmental controls are important for maintaining API quality throughout storage.
Good pharmaceutical handling practices include:
The exact storage temperature and shelf-life should be taken from the applicable manufacturer stability program rather than assigning an unsupported universal value.
The development of antiviral medicines requires APIs with consistent chemical identity, purity, and reproducible performance. Penciclovir Sodium provides a defined salt form of penciclovir for pharmaceutical research and manufacturing applications.
Its relevance to antiviral drug development includes research into herpesvirus replication, formulation development, analytical method development, impurity profiling, and stability evaluation.
The API can therefore form an important component of pharmaceutical development programs where penciclovir-based antiviral activity is required.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.2% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 1.0% |